ClinicalTrials.gg
Drug

Lamotrigine clinical trials

Also written Lamictal and Lamictal® 200 mg.

studies test it
137
open now
3
in phase 3
38
first study started
1993

How each study uses Lamotrigine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lamotrigine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 1994 · LAMICTAL · NDA 020241 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lamotrigine
95
LAMICTAL XR
6
Lamotrigine Tablets 25 mg
4
Lamotrigine tablet
3
Lamotrigine 25 mg Chewable Tablets
2

Brand

Lamictal
40
Lamictal® 200 mg
2
Lamictal 300 mg
1
Lamictal 50mg
1

Other names

3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine
1

Studies by the year they started

135 studies that test it; most in 2002 (13)

Studies that test Lamotrigine, by start year
YearStudies
19931
19951
19971
20003
200213
200312
200412
20058
200610
200710
20089
20092
20106
20116
20127
20133
20144
20155
20162
20172
20181
20194
20204
20213
20223
20231
20242

By phase

A phase 1/2 study counts in both.

Phase 1
38
Phase 2
20
Phase 3
38
Phase 4
31
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 60 · Other 77

GlaxoSmithKline (32) · Dr. Reddy's Laboratories Limited (8) · Teva Pharmaceuticals USA (4) · University of Texas Southwestern Medical Center (3) · University Hospitals Cleveland Medical Center (3) · Mylan Pharmaceuticals Inc (2) · Dent Neuroscience Research Center (2) · University of Maryland, Baltimore (2)

Often tested with

Tested in the same studies.

Valproic Acid (10) · Levetiracetam (8) · Lithium (6) · Carbamazepine (5) · Zonisamide (4) · Oxcarbazepine (4) · Topiramate (4) · Fluoxetine (4)

Studies

Open first, then newest update. How each study uses Lamotrigine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 137

See all 137 studies that test Lamotrigine →

Given beside what is tested · 8 — Lamotrigine is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Lamotrigine

Codes

What other systems call Lamotrigine · ClinicalTrials.gg INT006668

  • MeSH (NLM) D000077213LamotrigineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) U3H27498KSLAMOTRIGINEConfirmed FDA, NLM, Wikidata
  • RxNorm 28439Confirmed FDA, Wikidata
  • Wikidata Q410346lamotrigineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C38703LamotrigineOne source FDA
  • DrugBank DB00555One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.